163 related articles for article (PubMed ID: 17436027)
1. The time for cost-effectiveness in the new European Union member states: the development and role of health economics and technology assessment in the mirror of the Hungarian experience.
Gulácsi L
Eur J Health Econ; 2007 Jun; 8(2):83-8. PubMed ID: 17436027
[TBL] [Abstract][Full Text] [Related]
2. Comparing Use of Health Technology Assessment in Pharmaceutical Policy among Earlier and More Recent Adopters in the European Union.
Beletsi A; Koutrafouri V; Karampli E; Pavi E
Value Health Reg Issues; 2018 Sep; 16():81-91. PubMed ID: 30316029
[TBL] [Abstract][Full Text] [Related]
3. Should Hungary Pay More for a QALY Gain than Higher-Income Western European Countries?
Kovács S; Németh B; Erdősi D; Brodszky V; Boncz I; Kaló Z; Zemplényi A
Appl Health Econ Health Policy; 2022 May; 20(3):291-303. PubMed ID: 35041177
[TBL] [Abstract][Full Text] [Related]
4. Similarities and differences between stakeholders' opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey.
Vokó Z; Cheung KL; Józwiak-Hagymásy J; Wolfenstetter S; Jones T; Muñoz C; Evers SM; Hiligsmann M; de Vries H; Pokhrel S;
Health Res Policy Syst; 2016 May; 14(1):38. PubMed ID: 27230485
[TBL] [Abstract][Full Text] [Related]
5. Health Economics as Rhetoric: The Limited Impact of Health Economics on Funding Decisions in Four European Countries.
Franken M; Heintz E; Gerber-Grote A; Raftery J
Value Health; 2016 Dec; 19(8):951-956. PubMed ID: 27987645
[TBL] [Abstract][Full Text] [Related]
6. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
[TBL] [Abstract][Full Text] [Related]
7. Role of health technology assessment in the process of implementation of the EU Transparency Directive: relevant experience from Central Eastern European countries.
Kolasa K; Kalo Z; Zah V; Dolezal T
Expert Rev Pharmacoecon Outcomes Res; 2012 Jun; 12(3):283-7. PubMed ID: 22812552
[TBL] [Abstract][Full Text] [Related]
8. Diversity and dynamics of patient cost-sharing for physicians' and hospital services in the 27 European Union countries.
Tambor M; Pavlova M; Woch P; Groot W
Eur J Public Health; 2011 Oct; 21(5):585-90. PubMed ID: 20884659
[TBL] [Abstract][Full Text] [Related]
9. Mental health economics: insights from Brazil.
Cruz L; Lima AF; Graeff-Martins A; Maia CR; Ziegelmann P; Miguel S; Fleck M; Polanczyk C
J Ment Health; 2013 Apr; 22(2):111-21. PubMed ID: 23574503
[TBL] [Abstract][Full Text] [Related]
10. Variability of cost-effectiveness estimates for pharmaceuticals in Western Europe: lessons for inferring generalizability.
Barbieri M; Drummond M; Willke R; Chancellor J; Jolain B; Towse A
Value Health; 2005; 8(1):10-23. PubMed ID: 15841890
[TBL] [Abstract][Full Text] [Related]
11. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D
Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291
[TBL] [Abstract][Full Text] [Related]
12. The role of health economics in the evaluation of surgery and operative technologies.
Taylor M
Surgery; 2017 Feb; 161(2):300-304. PubMed ID: 28096035
[TBL] [Abstract][Full Text] [Related]
13. Health technology assessment of medical devices: What is different? An overview of three European projects.
Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
[TBL] [Abstract][Full Text] [Related]
14. Economic Burden of Bladder Cancer Across the European Union.
Leal J; Luengo-Fernandez R; Sullivan R; Witjes JA
Eur Urol; 2016 Mar; 69(3):438-47. PubMed ID: 26508308
[TBL] [Abstract][Full Text] [Related]
15. [A proposal for reforming psychologists' training in France and in the European Union].
Bouchard JP
Encephale; 2009 Feb; 35(1):18-24. PubMed ID: 19250989
[TBL] [Abstract][Full Text] [Related]
16. [Policy developments of health technology assessment in the European Union].
Baran-Kooiker A; Czech M; Hołownia-Voloskova M
Postepy Biochem; 2019 Nov; 65(4):319-321. PubMed ID: 31945287
[TBL] [Abstract][Full Text] [Related]
17. Health economics in developing countries.
Abel-Smith B
J Trop Med Hyg; 1989 Aug; 92(4):229-41. PubMed ID: 2503621
[TBL] [Abstract][Full Text] [Related]
18. Values and evidence colliding: health technology assessment in child health.
Ungar WJ; Prosser LA; Burnett HF
Expert Rev Pharmacoecon Outcomes Res; 2013 Aug; 13(4):417-9. PubMed ID: 23977967
[No Abstract] [Full Text] [Related]
19. Variability in healthcare treatment costs amongst nine EU countries - results from the HealthBASKET project.
Busse R; Schreyögg J; Smith PC
Health Econ; 2008 Jan; 17(1 Suppl):S1-8. PubMed ID: 18186039
[No Abstract] [Full Text] [Related]
20. 'Health Economics' and the evolution of economic evaluation of health technologies.
Hutton J
Health Econ; 2012 Jan; 21(1):13-8. PubMed ID: 22147623
[No Abstract] [Full Text] [Related]
[Next] [New Search]
